Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimization Strategy for the Prevention of Acute Mountain Sickness by Remote Ischemic Preconditioning Combined With Acetazolamide

NCT05023941 is registered in ClinicalTrials.gov with Ji Xunming,MD,PhD as lead sponsor.

NCT NCT05023941
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05023941 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimization Strategy for the Prevention of Acute Mountain Sickness by Remote Ischemic Preconditioning Combined With Acetazolamide
Lead sponsor
Ji Xunming,MD,PhD
Phase
Phase 4
Overall status
Completed
Start date
December 1, 2021
Completion date
August 30, 2022
Enrollment
252 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute mountain sickness